Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EPA/ALNEV stock hub

EPA/ALNEV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/ALNEVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Euronext Paris

Market data

Price

Recent price action with selectable time range.

EPA/ALNEVEPA/ALNEV

—

Loading chart…

In the news

Latest news · EPA/ALNEV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-23.2

P25 n/aP50 n/aP75 n/a

ROIC-18.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/ALNEV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

EUR

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	16
Employees Change	-4%
Employees Change Percent	-20
Enterprise value	EUR 132,245
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FR00140077X1
Last refreshed	2026-05-10
Market cap	EUR 95
Price	EUR 0
Price currency	EUR
Rev Per Employee	12,454.19x
Sector	Healthcare
Sic	2836
Symbol	epa/ALNEV
Website	https://www.neovacs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4,587,298.95%
EV Earnings	-0.03x
EV/FCF	-0.04x
EV/Sales	0.66x
FCF yield	-3,274,976.84%
P/B ratio	0x
P/S ratio	0x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -2.9M
Net Income	EUR -4.4M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-2,738.87%
Profit Per Employee	EUR -272,371
ROA	-10.66
Roa5y	-12.65
ROCE	-29.97
ROE	-23.23
Roe5y	-51.08
ROIC	-18.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-93.15%
Cagr15y	-84.67%
Cagr1y	-100%
Cagr3y	-99.8%
Cagr5y	-98.81%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	-75.8x
Revenue Growth Q	-59.81x
Revenue Growth Years	0x
Revenue Growth3 Y	-27.98x
Revenue Growth5 Y	182.27x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.01
Assets	EUR 23.1M
Cash	EUR 38,511
Current Assets	EUR 2.7M
Current Liabilities	EUR 4M
Debt	EUR 170,663
Debt Equity	EUR 0.01
Debt FCF	EUR -0.05
Equity	EUR 18.9M
Interest Coverage	-8.71
Liabilities	EUR 4.2M
Long Term Assets	EUR 20.4M
Long Term Liabilities	EUR 170,268
Net Cash	EUR -132,152
Net Cash By Market Cap	EUR -139,107
Net Debt Equity	EUR 0.01
Tangible Book Value	EUR 18.9M
Tangible Book Value Per Share	EUR 39.63
WACC	303.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.67
Net Working Capital	EUR -1.2M
Quick ratio	0.65
Working Capital	EUR -1.3M
Working Capital Turnover	EUR -0.14

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-100%
200-day SMA	0.17
3Y total return	-100%
50-day SMA	0
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	424,000,000
All Time High Change	-100%
All Time High Date	2011-06-06
All Time Low	0
All Time Low Change	0%
All Time Low Date	2026-04-15
ATR	0
Beta	42.05
Beta1y	0.95
Beta2y	1.2
Ch YTD	-97.7
High	0
High52	14.1
High52 Date	2025-05-08
High52ch	-100%
Low	0
Low52	0
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-71.43%
Price vs 200-day SMA	-99.88%
RSI	26.06
RSI Monthly	46.47
RSI Weekly	37.01
Sharpe ratio	-3.09x
Sortino ratio	-5.06
Tr YTD	-97.7
Tr15y	-100%
Tr1m	-66.67%
Tr3m	-92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -5.7M
Operating margin	-2,866.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-233,227
Shares Out	476,625

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -3.1M
Average Volume	60,345,754.25x
Bv Per Share	39.63
CAPEX	EUR -16,275
Ch10y	-100
Ch15y	-100
Ch1m	-66.67
Ch1y	-100
Ch3m	-92
Ch3y	-100
Ch5y	-100
Ch6m	-99.46
Change	0%
Change From Open	-50
Close	0
Days Gap	100
Depreciation Amortization	190,459
Dollar Volume	19,647.8
Earnings Date	2026-05-14
EBIT	EUR -5.7M
EBITDA	EUR -5.5M
EPS	EUR -9.14
F Score	2
FCF	EUR -3.1M
FCF EV Yield	-2,352.62x
FCF Per Share	EUR -6.53
Financing CF	4,326,675
Fiscal Year End	December
Founded	1,993
Income Tax	EUR -1.1M
Investing CF	-1,424,822
Is Primary Listing	1
Last Earnings Date	2025-12-05
Last Report Date	2025-06-30
Last Split Date	2025-07-18
Last Split Type	Reverse
Ma150	0.02
Ma150ch	-99.08%
Ma20	0
Ma20ch	-33.33%
Net CF	-193,100
Next Earnings Date	2026-05-14
Open	0
Position In Range	0
Ppne	325,878
Price Date	2026-05-08
Ptbv Ratio	0
Relative Volume	1.76x
Revenue	199,267x
Tax By Revenue	-551.89x
Tr6m	-99.46%
Volume	98,239,222
Z Score	-4.52

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EPA/ALNEV pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/ALNEV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

EPA/ALNEV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

26.1

Below 30: short-term oversold

Price vs 200-day MA

-99.9%

50/200-day relationship not available

Beta (5Y)

42.05

More volatile than the market

Sharpe ratio

-3.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/ALNEV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/ALNEV stock rating?

epa/ALNEV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/ALNEV analysis?

The full report lives at /stocks/epa/ALNEV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/ALNEV?

The latest report frames epa/ALNEV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/ALNEV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.